TY - JOUR PY - 2022// TI - Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women JO - AIDS A1 - Delanymoretlwe, Sinead A1 - Celum, Connie A1 - Pence, Brian W. A1 - Hightow-Weidman, Lisa A1 - Powers, Kimberly A. A1 - Pettifor, Audrey A1 - Giovenco, Danielle A1 - Hosek, Sybil A1 - Donnell, Deborah A1 - Anderson, Peter L. A1 - Mgodi, Nyaradzo A1 - Bekker, Linda-Gail SP - ePub EP - ePub VL - ePub IS - ePub N2 - OBJECTIVE: To estimate the effect of intimate partner violence (IPV) on oral PrEP adherence among adolescent girls and young women (AGYW).

DESIGN: We conducted a secondary analysis of data from HIV Prevention Trials Network 082 (HPTN 082), a multisite prospective study designed to assess oral PrEP adherence among AGYW in southern Africa.

METHODS: We estimated the relative prevalence of high PrEP adherence 3 and 6 months after initiation among AGYW 16-25 years who reported a history of any IPV in the past year at enrollment versus AGYW who did not, both overall and by age. High adherence was defined as an intracellular tenofovir-diphosphate concentration at least 700 fmol/punch in dried blood spots.

RESULTS: Among 409 PrEP-initiating AGYW, half (49%) reported experiencing any IPV by a current/recent partner in the year prior to enrollment. Overall, a similar proportion of AGYW who reported IPV had high PrEP adherence at months 3 and 6 as AGYW who did not report IPV. There was, however, evidence of effect modification by age at month 3: among AGYW less than 21 years, those who reported IPV were less than half as likely to have high adherence [adjusted PR (aPR) = 0.43, 95% confidence interval (CI) 0.22-0.86]; among AGYW aged 21 years, those who reported IPV were more than twice as likely to have high adherence (aPR = 2.21, 95% CI 1.34-3.66). At month 6, effect estimates within each age stratum were consistent in direction to those at month 3.

CONCLUSION: IPV events may either impede or motivate PrEP adherence among African AGYW, with age appearing to be an important consideration for IPV-related adherence interventions.

Language: en

LA - en SN - 0269-9370 UR - http://dx.doi.org/10.1097/QAD.0000000000003216 ID - ref1 ER -